Guillaume Paré

Canada Research Chair in Genetic and Molecular Epidemiology

Tier 2 - 2017-11-01
Renewed: 2014-11-01
McMaster University
Canadian Institutes of Health Research

905-527- 4322 ext. 40356

Coming to Canada From

Harvard University

Research involves

Using genetic and molecular markers to help prevent strokes.

Research relevance

This research will help explain why strokes happen, and identify people most at risk, in order to prevent strokes and reduce healthcare and disability costs.

Striking Back at Strokes

The statistics are sobering. Every 10 minutes a Canadian has a stroke. Fifteen per cent of stroke sufferers will die, and half of stroke survivors are left with moderate to severe disabilities.

Dr. Guillaume Paré, Canada Research Chair in Genetic and Molecular Epidemiology, is working to reverse these grim statistics by developing more effective stroke prevention strategies.

His innovative approach involves using cutting-edge technology to identify the genetic traits that set a stroke in motion, and to better determine who is at risk. For example, by analyzing biological molecules found in blood, he is investigating whether some people carry a gene that makes their blood more likely to clot and interrupt blood flow to the brain.

Paré is also analyzing data from thousands of stroke cases in Canada to reveal more about the role of known risk factors, such as high blood pressure.

Paré’s research will help identify essential information about individuals at risk, offering valuable insights into preventative measures, drug therapies and lifestyle changes that could reduce the number of strokes in Canada.